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cis-Urocanic Acid Enhances Prostaglandin E2 Release
and Apoptotic Cell Death via Reactive Oxygen
Species in Human Keratinocytes
Kazuyo Kaneko1, Susan L. Walker1, Joey Lai-Cheong1, Mary S. Matsui2, Mary Norval3 and Antony R. Young1
Urocanic acid (UCA) is a major UVR-absorbing skin molecule that undergoes trans to cis photoisomerization in
the epidermis following UVR exposure. Murine studies have established that cis-UCA is an important mediator
of UVR-induced immune suppression, but little is known about its signaling pathway. We have previously
demonstrated that treatment of normal human epidermal keratinocytes with cis-UCA resulted in increased
synthesis of prostaglandin E2 (PGE2) and cell death. Here, using immortalized human keratinocytes, we report
that cis-UCA but not trans-UCA generates reactive oxygen species (ROS) in a dose-dependent manner and that
the natural antioxidant a-tocopherol can reduce this ROS generation, subsequent PGE2 release, and apoptotic
cell death. Western blot analysis revealed that cis-UCA leads to a transient phosphorylation of EGFR as well as
downstream mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK) and p38.
Pharmacological inhibition of their activity attenuated PGE2 release induced by cis-UCA. After transient
activation, cis-UCA downregulated EGFR protein expression that corresponded to activation of caspase-3. In
addition, pretreatment with a-tocopherol inhibited EGFR downregulation and caspase-3 activation induced by
cis-UCA. These results suggest that cis-UCA exerts its effects on human keratinocytes via intracellular ROS
generation that modulates EGFR signaling and subsequently induces PGE2 synthesis and apoptotic cell death.
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INTRODUCTION
Exposure to solar UVR suppresses cutaneous cell-mediated
immunity. UVR-induced immune suppression has been im-
plicated in diverse pathologies including skin cancers, infectious
diseases, failure of vaccination, and some autoimmune diseases
as well as phototherapy (Norval, 2006). The pathway leading to
immunosuppression following UVR is complex but is initiated
by chromophores located in the epidermis. Evidence from
mouse models indicate that DNA and urocanic acid (UCA) are
critical chromophores (De Fabo and Noonan, 1983; Kripke
et al., 1992). Upon exposure to UVR, UCA undergoes a trans to
cis isomerization until equilibrium is reached with B60–70%
cis-UCA. Topical or systemic application of cis-UCA mimics
many aspects of UVR-induced immune suppression in mice
(Gibbs et al., 2008). Furthermore, treatment of mice with a cis-
UCA mAb restores many of the downregulatory changes in
local and systemic immunity that follow UVR (El-Ghorr and
Norval, 1995; Kondo et al., 1995; Moodycliffe et al., 1996).
However, the pathways involved in cis-UCA-induced immune
suppression remain poorly understood. To date, the target cell
for cis-UCA-mediated effects has not been identified, but as the
photoisomerization to cis-UCA takes place in the epidermis,
keratinocytes may be a potential target for cis-UCA.
Our previous microarray analysis using primary cultures of
human keratinocytes demonstrated that cis-UCA but not
trans-UCA upregulates the expression of UVR-inducible
genes associated with oxidative stress, cell growth arrest,
apoptosis, and immunomodulatory mediators. Among them,
cyclooxygenase-2 (COX-2), the rate-limiting enzyme in
prostanoid biosynthesis, was most dramatically upregulated
by cis-UCA, resulting in an enhanced secretion of prosta-
glandin E2 (PGE2) (Kaneko et al., 2008). Jaksic et al. (1995)
have also shown a synergistic effect of cis-UCA and
histamine on increased production of PGE2 by human
keratinocytes. Release of immunomodulatory mediators by
keratinocytes promotes immune suppression locally and
systemically following UVR exposure. PGE2 is considered a
particularly important mediator as it can initiate production
of the immunosuppressive cytokine IL-4, followed by IL-10
(Shreedhar et al., 1998). In addition, the recent demonstration
that mice deficient in proapoptotic BH3-interacting death
domain protein showed resistance to UVR-induced suppression
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of local and systemic contact hypersensitivity responses as well
as reduced level of apoptosis in epidermal keratinocytes and
Langerhans cells following UVR exposure implicates a link
between induction of apoptosis and UVR-induced immune
suppression (Pradhan et al., 2008).
It is well established that UVR generates reactive oxygen
species (ROS) within cells and the ROS activates EGFR in a
ligand-independent manner. This further activates downstream
mitogen-activated protein kinase (MAPK) signaling that leads to
COX-2 expression and subsequent PGE2 production (Rundhaug
and Fischer, 2008). Intracellular ROS generation is also intima-
tely associated with apoptosis and the activation of caspase-3
has been suggested to be a downstream event (Mates et al.,
2008). As cis-UCA was demonstrated to upregulate many
oxidative stress-related genes in primary human keratinocytes
(Kaneko et al., 2008), in this study we examined the involvement
of intracellular ROS in cis-UCA-induced PGE2 synthesis and
apoptotic cell death using immortalized human keratinocytes.
RESULTS
cis-UCA enhances PGE2 synthesis via a COX-2-dependent
pathway
That cis-UCA induces a dose-dependent increase in COX-2
mRNA and PGE2 release has been demonstrated in primary
human keratinocytes (Kaneko et al., 2008). To further test if
cis-UCA induces PGE2 production in a COX-2-dependent
manner, we used nTERT keratinocytes derived from human
primary keratinocytes immortalized with human telomerase
reverse transcriptase (Dickson et al., 2000). nTERT keratino-
cytes showed a similar dose-dependent increase in PGE2
release 24 hours after cis-UCA treatment (Figure 1d). cis-UCA
but not trans-UCA also significantly upregulated the expres-
sion of COX-2 protein after 2 and 6 hours (Figure 1a–c). An
increase in PGE2 release induced by cis-UCA was observed
after 6 hours (Figure 1e). In addition, the COX-inhibitor indo-
methacin abrogated the increase in PGE2 release induced by
cis-UCA (Figure 1f), suggesting that cis-UCA-induced PGE2
synthesis is mediated by a COX-2-dependent pathway.
cis-UCA induces cell growth arrest and apoptotic cell death
Treatment of primary human keratinocytes with cis-UCA
resulted in the release of mono- and oligonucleosomes into
the cytoplasm, and distinctive morphological changes, such
as spurring and flattening (Figure 2a–c). Similar morpho-
logical changes were observed in nTERT keratinocytes
(Figure 2c). cis-UCA-induced cell growth arrest and/or death
was further evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
dimethyl tetrazolium bromide (MTT) cell proliferation and
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Figure 1. cis-Urocanic acid (UCA) increases cyclooxygenase-2 (COX-2) protein expression and prostaglandin E2 (PGE2) release, and the COX inhibitor
indomethacin abrogates PGE2 synthesis induced by cis-UCA in nTERT keratinocytes. (a) COX-2 protein expression 6 hours after treatment, (b) kinetics of COX-2
protein expression, and (c) optical density values for COX-2 relative to actin in response to cis-UCA. (d–f) PGE2 release into the culture medium; (d) 24 hours
after treatment, (e) kinetics in response to cis-UCA, and (f) pretreatment with 0.5mM indomethacin for 1 hour before treatment with phosphate-buffered saline
(PBS) or cis-UCA for 24 hours. Results are expressed as mean±SE of three independent experiments. *Po0.05, **Po0.01 versus PBS control (d, f) or before
treatment (c, e). The blots are representative of three independent experiments.
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viability assay in nTERT keratinocytes. As shown in Figure 2d,
cis-UCA significantly decreased MTT cell proliferation and
viability of keratinocytes in a dose-dependent manner. Also,
100mgml–1 trans-UCA slightly decreased MTT cell prolifera-
tion and viability. To determine if this was due to apoptosis,
cells were stained with annexin V-FITC and propidium iodide
following UCA treatment and analyzed by flow cytometry. As
shown in Figure 2e, 50 and 100mgml–1 cis-UCA clearly
induced early apoptosis after 24 hours, with 25 and 37% of
early apoptotic (annexin positive) cells in the 50 and
100mgml–1 cis-UCA treatment groups, respectively, and only
6% in the phosphate-buffered saline (PBS) control. This cell
population shifted toward the late stage of apoptosis (annexin
and propidium iodide positive) 48 hours after treatment with
100mgml–1 cis-UCA. In contrast, 10 mgml–1 cis-UCA and
100mgml–1 trans-UCA did not increase either early or late
apoptotic cells at 24 hours.
As shown in Figure 2f, the electron microscopy analysis
also showed that 100mgml–1 cis-UCA-treated nTERT cells
exhibited hallmark changes of apoptosis such as irregular
plasma membrane and nuclear envelope shape, condensa-
tion of nuclear chromatin, blebbing, and loss of nucleoli at
24 hours, indicating that the cells had left the latent phase
of apoptosis, but had not reached the execution phase
with cytoplasmic spillage. These changes were not observed
in PBS or trans-UCA-treated cells. Taken together, these
observations suggest that keratinocytes exposed to cis-UCA
undergo growth arrest and apoptotic cell death.
cis-UCA induces the generation of intracellular ROS that
mediate PGE2 synthesis and apoptotic cell death
We have previously shown that cis-UCA significantly
increased the release of 8-isoprostane, a biomarker for
photo-oxidative stress, in primary human keratinocytes
(Kaneko et al., 2008). To determine whether cis-UCA induces
generation of ROS in nTERT keratinocytes, intracellular ROS
were visualized with the carboxydichlorofluorescein, which
is oxidized by ROS within cells and emits green fluorescence.
As shown in Figure 3a, cis-UCA induced an increase in
intracellular ROS in a dose-dependent manner, whereas only
a background level of fluorescence was observed after
treatment with trans-UCA.
NADPH (nicotinamide adenine dinucleotide phosphate)
oxidase is a potential cellular source for the extended
production and enhanced level of ROS after exposure of
skin to UVR. To assess whether this enzyme is involved in the
production of ROS induced by cis-UCA, cells were pretreated
with the NADPH oxidase inhibitor, diphenyleneiodonium
chloride, and analyzed for ROS generation. As shown in
Figure 3b, diphenyleneiodonium chloride reduced ROS
generation induced by cis-UCA, suggesting that NADPH
oxidase is at least in part involved in cis-UCA-induced ROS
generation.
The natural antioxidant a-tocopherol effectively scavenges
UVR-induced ROS (Jin et al., 2007); therefore, further studies
assessed its ability to inhibit the cis-UCA-induced increase in
PGE2 release and apoptotic cell death. As shown in Figure 3c,
a-tocopherol reduced intracellular ROS generation in a dose-
dependent manner. Pretreatment with 10 mM a-tocopherol
resulted in reduced production of PGE2 induced by cis-UCA
(Figure 3d). To inhibit apoptotic cell death, a higher
concentration of a-tocopherol was required, and 100 mM a-
tocopherol significantly inhibited cis-UCA-induced MTT
reduction and early apoptosis (Figure 3e and f). These results
suggest that cis-UCA-induced PGE2 synthesis and apoptotic
cell death can be attributed to enhanced production of
intracellular ROS in human keratinocytes.
cis-UCA increases PGE2 release mediated through activation of
EGFR and downstream MAPKs
We further examined the involvement of the EGFR/MAPK
signaling pathway in cis-UCA-induced PGE2 release. As
shown in Figure 4a and b, cis-UCA but not trans-UCA
induced a transient increase in phosphorylation of EGFR
2hours after treatment. The expression of phosphorylated
EGFR then returned to the basal level at 6 hours and was not
detected at 24 hours. cis-UCA also decreased the constitutive
expression of EGFR after 24 hours. In addition, as shown in
Figure 4d and e, cis-UCA but not trans-UCA induced a
transient increase in phosphorylation of the downstream
MAPKs, extracellular signal-regulated kinase (ERK) and p38.
The phosphorylation of ERK peaked 2hours after treatment
with cis-UCA, returned to the basal level after 6 hours, and
then diminished, as did the EGFR phosphorylation. The
kinetics of the phosphorylation of p38 were slower and
prolonged compared with ERK, with peaking at 6 hours. In
contrast, the phosphorylation of c-Jun N-terminal kinase
(JNK) by cis-UCA was not observed over this time period.
Consistent with these observations, pretreatment with the
EGFR kinase inhibitor AG1478, ERK inhibitor PD98059, and
p38 inhibitor SB202190 inhibited the increase in PGE2
release induced by cis-UCA. The JNK inhibitor SP600125
did not have a similar inhibitory effect (Figure 4c and f).
These results indicate that cis-UCA-induced PGE2 synthesis
requires activation of EGFR and downstream ERK and p38
MAPK signaling.
cis-UCA-induced apoptotic cell death involves a caspase-3-
mediated pathway
To clarify the involvement of caspase-3 in cis-UCA-induced
apoptotic cell death, keratinocytes were treated with cis-UCA
and the expression of caspase-3 was analyzed by immuno-
Figure 2. cis-Urocanic acid (UCA) increases apoptotic cells in primary and nTERT keratinocytes. (a) Mono- and oligonucleosome release 24 hours after
treatment, (b, c) light microscope images 24 hours after treatment (scale bars¼100 mm in b and 50 mm in c), (d) MTT cell proliferation/viability 24 hours after
treatment, and (e) flow cytometric analysis of apoptotic cells. The values indicate the percentage of living (lower left quadrant), early apoptotic (lower right
quadrant), late apoptotic (upper right quadrant), and dead (upper left quadrant) cells. Similar results were obtained in at least three independent experiments.
(f) Electron microscope images 24 hours after treatment (scale bars¼2 or 10 mm as indicated). (a–c) Primary human keratinocytes and (c–f) nTERT keratinocytes.
(a, d) Results are expressed as mean±SE of three independent experiments. *Po0.05, ***Po0.001 versus phosphate-buffered saline (PBS) control.
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blotting. As shown in Figure 5a and b, cis-UCA markedly
increased the expression of cleaved caspase-3 at 24 hours in a
dose-dependent manner, which was consistent with the
downregulation of the EGFR protein expression (Figure 4b).
In addition, pretreatment with 100mM a-tocopherol clearly
inhibited the cleavage of caspase-3 and the degradation of
EGFR induced by cis-UCA (Figure 5c).
DISCUSSION
This study provides the evidence that cis-UCA can induce
generation of ROS within human keratinocytes (Figure 3a).
Previously, NADPH oxidase had been reported as the major
source of UVR-induced ROS in human keratinocytes (Beak
et al., 2004; Valencia and Kochevar, 2008). In agreement
with this, our results suggest that NADPH oxidase is likely to
play a role, at least in part, in cis-UCA-induced ROS
generation (Figure 3b). This activation may involve signaling
through the membrane receptor for cis-UCA, although the
identity of such a receptor remains elusive and controversial
(Walterscheid et al., 2006; Woodward et al., 2006; Kaneko
et al., 2009). Recent evidence suggests that cis-UCA has the
capacity to decrease the intracellular pH in a mildly acidic
extracellular environment (pH o6.7) (Laihia et al., 2010).
However, this is unlikely to be the underlying mechanism in
this study as the pH of the medium containing cis-UCA was
between 7.0 and 7.4 before and 24 hours after incubation
(data not shown). The mitochondrial electron transport chain
is another potential cellular source for ROS after exposure of
skin to UVR (Gniadecki et al., 2000), and products of
membrane lipid peroxidation induce mitochondrial ROS
formation (Landar et al., 2006). As our earlier study indicated
that cis-UCA induces lipid peroxidation in primary human
keratinoytes (Kaneko et al., 2008), it is possible that the
mitochondrial pathway also mediates cis-UCA-induced
generation of ROS.
In contrast to our finding, Rinaldi et al. (2006) have shown
that cis-UCA inhibits the generation of extracellular super-
oxide while not affecting the generation of intracellular
superoxide or other ROS in bovine neutrophils. Although
they did not test trans-UCA, this inhibitory effect is unlikely to
be specific to the cis-isomer because it has previously been
shown that either trans- or cis-UCA inhibits the respiratory
burst activity of human neutrophils (Kivisto et al., 1996). UCA
is an imidazole compound and, as well as other imidazole
derivatives including histidine and histamine, both UCA
isomers are known to act as hydroxyl radical scavengers in
aqueous solution (Kammeyer et al., 1999). The effect
observed in their in vitro system may derive from the radical
scavenging activity of exogenous UCA. Whether cis-UCA
can penetrate cell membranes remains to be determined and,
if a membrane receptor mediates in its activity, cis-UCA may
act as a radical initiator rather than as a scavenger.
Phosphorylation of EGFR via UVR-generated ROS has
been well documented (Huang et al., 1996; Peus et al.,
1998). This phosphorylation provides a necessary signal to
induce COX-2 expression and subsequent PGE2 production
in keratinocytes (Ashida et al., 2003; Rundhaug and Fischer,
2008). Similar to UVR, cis-UCA activated the EGFR and
downstream MAPK signaling pathways that are required for
PGE2 synthesis in human keratinocytes (Figure 4). It has been
suggested that COX-2 expression and PGE2 levels are
regulated by different MAPK signaling pathways depending
on the cell type and stimulus (Chen et al., 2001; Ashida et al.,
2003; Cui et al., 2004; Kim and Kim, 2004). Our results
showed that cis-UCA induces phosphorylation of ERK and
p38 but not JNK (Figure 4e). ERK and p38 inhibitors but not a
JNK inhibitor also suppressed cis-UCA-induced PGE2 release
(Figure 4f). In contrast, other groups have demonstrated that
phosphorylation of JNK as well as ERK and p38 is induced by
UVB and 2,20-azobis (2-amidinopropane) di-hydrochloride
(AAPH), a water-soluble free radical initiator, in HaCaT
keratinocytes. However, these inhibition studies showed that
the induction of COX-2 expression by UVB or AAPH was not
blocked by the inhibition of JNK but by the inhibition of ERK
and p38 (Ashida et al., 2003; Cui et al., 2004), suggesting that
UVB and AAPH induce COX-2 induction independently of
the JNK signaling. This supports our finding that ERK and p38
signaling are the major pathways involved in cis-UCA-
induced PGE2 synthesis in keratinocytes. The mechanism
by which cis-UCA differentially activates MAPKs remains
elusive, but different ROS elicit different MAPK activation
patterns (Baas and Berk, 1995).
As well as PGE2 synthesis, keratinocytes exposed to cis-
UCA underwent cell growth arrest and apoptotic cell death
(Figure 2). This observation is consistent with recent reports
showing that dermal injection of cis-UCA results in a high
number of TUNEL-positive apoptotic cells in mouse skin
(Sreevidya et al., 2010) and also that cis-UCA induces the
irreversible termination of proliferation of two human bladder
carcinoma and one human metastatic melanoma cell lines
(Laihia et al., 2009, 2010). We further demonstrated that cis-
UCA induces apoptotic cell death via intracellular ROS
generation (Figure 3). Accumulating evidence indicates that
intracellular ROS activates signaling pathways, leading to the
activation of caspase-3 and subsequent apoptosis (Ueda
et al., 2002). In human keratinocytes, it has been reported
that treatment with H2O2 or singlet oxygen induces cleavage
of caspase-3 as well as apoptosis (Zhuang et al., 2003;
Zuliani et al., 2005). We also detected dose-dependent
upregulation of the cleaved active form of caspase-3 at
Figure 3. cis-Urocanic acid (UCA) generates reactive oxygen species (ROS) mediated through nicotinamide adenine dinucleotide phosphateoxidase
(NADPH), and the natural antioxidant a-tocopherol reduces prostaglandin E2 (PGE2) increase and apoptotic cell death induced by cis-UCA in nTERT
keratinocytes. (a–c) ROS generation at 2 hours after treatment. Cells were pretreated with 10 mM diphenyleneiodonium chloride (DPI; b) or 10–100 mM
a-tocopherol (c) before cis-UCA treatment (scale bar¼200 mm). (d) PGE2 release into the culture medium for 24 hours, (e) MTT cell proliferation/viability, and (f)
flow cytometric analysis of apoptotic cells after 24 hours. Cells were pretreated with 10 (d) or 100 mM (e, f) a-tocopherol before cis-UCA treatment. (d, e) Results
are expressed as mean±SE of three independent experiments. *Po0.05, **Po0.01. Similar results were obtained in at least three independent experiments.
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24 hours after cis-UCA treatment (Figure 5a and b) and this
activation was blocked by pretreatment with the antioxidant
a-tocopherol (Figure 5c). Similar activation of caspase-3 by
cis-UCA in human melanoma cells has been observed
in vitro and in vivo (Laihia et al., 2010). Moreover, expression
of EGFR protein was downregulated by cis-UCA after
24 hours (Figures 4b and 5b), and a-tocopherol inhibited this
downregulation (Figure 5c). EGFR signaling is known to
regulate cell survival, proliferation, and migration (Pastore
et al., 2008). Downregulation of EGFR protein expression has
been seen during apoptosis in response to various stimuli
including UVR, singlet oxygen, and tumor necrosis factor-a
(Bae et al., 2001; He et al., 2003, 2006; Zhuang et al., 2003).
Overexpression of cleavage-deficient EGFR mutant also
delayed the apoptosis progression in HaCaT keratinocytes
(He et al., 2006). Using purified EGFR, Bae et al. (2001) have
demonstrated that caspase-3 exhibits the ability to cleave
EGFR. This was further extended by other groups showing
that UVA and singlet oxygen produced by Rose Bengal
photosensitization induce downregulation of EGFR protein
expression and concurrent caspase-3 activation during
apoptosis, and that inhibition of caspase-3 reduces EGFR
degradation in human keratinocytes (He et al., 2003; Zhuang
et al., 2003). Taken together, it is possible that inactivation of
EGFR-mediated antiapoptotic signaling via active caspase-3
provides a mechanism to exacerbate cis-UCA-induced
apoptotic cell death, but, to prove this, additional studies
using genetic or pharmacological inhibition of EGFR and
caspase-3 are necessary.
Our data and that of others have clearly demonstrated the
capacity of cis-UCA to induce apoptosis. The quantity of cis-
UCA used in this study (10–100 mgml–1, equivalent to
70–700 mM) approximates the concentration found in human
skin (2-62 nmol cm–2, equivalent to 40–1,230mgml–1; Laihia
et al., 1998). However, apoptosis was not observed at the
lowest concentration of cis-UCA tested (10 mgml–1), although
PGE2 release was increased (Figures 1 and 2), suggesting that
a higher level of ROS is required to induce apoptosis than that
required for phosphorylation of EGFR to produce PGE2. One
study reports that there is no correlation between total UCA
concentration and minimal erythema dose (De Fine Olivarius
et al., 1997). This may be explained by recent evidence in
histidinemic mice suggesting that the formation of cyclobu-
tane pyrimidine dimers is more important than cis-UCA for
the induction of apoptosis (Barresi et al., 2011). Further
investigations are needed to understand the role of cis-UCA
on apoptosis induction and its relationship with immune
suppression in vivo.
Keratinocytes are an important candidate for the site of
action of cis-UCA. The data presented here suggest that the
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treatment. Results are expressed as mean±SE of three independent experiments. *Po0.05, **Po0.01.
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generation of intracellular ROS plays a critical role in signal
transduction induced by cis-UCA as well as by UVR in
human keratinocytes (Figure 6). Whether cis-UCA induces
ROS generation in other cell types remains to be determined,
but our findings fit well with previous mouse studies showing
that topical application of antioxidants inhibits the sup-
pression of contact hypersensitivity induced by cis-UCA
(Hemelaar and Beijersbergen van Henegouwen, 1996;
Steenvoorden and Beijersbergen van Henegouwen, 1999).
It is well known that ROS persist following UV irradiation
despite their short lifetime (Valencia and Kochevar, 2008).
The cellular source of these ROS is unclear at present but it is
possible that cis-UCA, which is found in the epidermis for at
least 2 weeks after a single UVR exposure (Kammeyer et al.,
1997), may induce ROS over the same period. Accumulating
evidence suggests that molecular mechanisms underlying
UVR-induced immune suppression may be linked by ROS
generation (Halliday, 2010). Our data further strengthen this
theory and support the idea that antioxidants may be of some
benefit against UVR-induced immune suppression and
photocarcinogenesis, as proposed by other studies (Afaq
and Mukhtar, 2006; Wright et al., 2006; Camouse et al.,
2009; Matsui et al., 2009).
MATERIALS AND METHODS
Cell culture
Primary cultures of epidermal keratinocytes were prepared from
biopsies taken from the unexposed buttock of healthy Caucasian
volunteers as described previously (Kaneko et al., 2008). The
procedure was approved by St Thomas’ Hospital Ethics Committee,
adhering to the Declaration of Helsinki Principles, and the donors
gave written informed consent. The primary and immortalized
nTERT human keratinocytes were grown in serum-free keratinocyte
medium supplemented with 50mgml–1 pituitary extract, 2.5 ngml–1
epidermal growth factor, 100 unitsml–1 penicillin, and 100 mgml–1
streptomycin (Invitrogen, Paisley, UK). The cells were maintained at
37 1C in 5% CO2 and passaged at 60% confluence. The medium was
changed every 2 to 3 days. For all experiments, cells were fed
24 hours before treatment and allowed to grow to 70–80%
confluence.
Urocanic acid
trans-UCA (99% purity) was obtained from Sigma-Aldrich Company
(Dorset, UK). cis-UCA was prepared from trans-UCA as previously
described and was 499% pure as determined by HPLC (Norval
et al., 1989). UCA isomers were dissolved in PBS and added to
keratinocyte cultures. PBS served as a baseline control.
Antibodies and reagents
Rabbit anti-human ERK, phospho-ERK, JNK, phospho-JNK and
phospho-p38 mAbs and rabbit anti-human COX-2, cleaved cas-
pase-3, EGFR, phospho-EGFR, and p38 polyclonal antibodies were
purchased from Cell Signaling Technology (Danvers, MA). Poly-
clonal rabbit anti-human actin and goat anti-rabbit secondary
antibodies were obtained from Abcam (Cambridge, UK) and
Invitrogen, respectively. Diphenyleneiodonium chloride, dl-a-toco-
pherol, indomethacin, MTT, SB202190, SP600125, and AG 1478
were purchased from Sigma-Aldrich. PD98059 was obtained from
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Figure 5. cis-Urocanic acid (UCA) induces activation of caspase-3
and downregulation of EGFR in nTERT keratinocytes. (a) Kinetics of
cleaved caspase-3 expression in response to cis-UCA, (b) expression
of cleaved caspase-3 and EGFR 24 hours after treatment, and (c)
expression of cleaved caspase-3 and EGFR 24hours after phosphate-buffered
saline (PBS) or cis-UCA treatment with or without pretreatment with 100 mM
a-tocopherol (a-Toc) for 24 hours. The blots are representative of four
independent experiments.
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Figure 6. A model of signaling pathways involved in cis-urocanic acid
(UCA)-induced prostaglandin E2 (PGE2) synthesis and apoptosis in human
keratinocytes. cis-UCA induces intracellular reactive oxygen species (ROS)
generation that transiently activates EGFR. Subsequent activation of the
downstream extracellular signal-regulated kinase (ERK) and p38 mitogen-
activated protein kinase (MAPK) signaling pathways leads to increased
transcription of cyclooxygenase-2 (COX-2) that then stimulates PGE2 release.
At higher concentrations, cis-UCA activates caspase-3 via intracellular ROS
generation that downregulates EGFR, resulting in apoptosis.
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Merck Chemicals (Hull, UK). a-Tocopherol and indomethacin were
dissolved in ethanol and the rest were dissolved in DMSO (Sigma-
Aldrich).
ROS detection
For detection of ROS, the Image-iT live green ROS detection kit
(Invitrogen) was used according to the manufacturer’s instructions.
Cells were analyzed by fluorescence microscopy using an Axiovert
40 CFL microscope (Carl Zeiss, Welwyn Garden City, UK). Tert-
butyl hydroperoxide, a short-chain lipid peroxide analog, served as a
positive control. Diphenyleneiodonium chloride and a-tocopherol
were added 1 and 24hours before cis-UCA treatment, respectively.
Measurement of PGE2 release
Supernatants were collected by centrifugation. The concentration of
PGE2 was determined by Parameter PGE2 Assay (R&D Systems
Europe, Abingdon, UK) according to the manufacturer’s instructions.
EGFR (AG1478) and MAPK (SB202190, PD98059, and SP600125)
inhibitors were added 1 hour before treatment and a-tocopherol was
added 24 hours before treatment.
MTT assay
A total of 2 104 cells per well were plated in a 96-well plate
and incubated with or without a-tocopherol for 24 hours at 37 1C.
cis-UCA or PBS was then added for a further 24 hours, and 3 hours
before the end of treatment 0.5% MTT solution in PBS was added to
each well. The culture medium was removed and 0.04M hydro-
chloric acid in isopropanol was added to each well to dissolve the
formazan. Following 5minutes of incubation at 37 1C, the optical
density of each well was measured at 550 nm.
Electron microscopy analysis
Cells were grown on glass coverslips. At 24 hours after treatment
with UCA, the coverslips were fixed with 2.5% glutaraldehyde in
phosphate buffer, pH 7.3, and then treated with 1% osmium
tetroxide in phosphate buffer, pH 7.3. Ultrathin sections were
stained with uranyl acetate and lead citrate. Micrographs were
obtained using a Hitachi H7600 transmission electron microscope
(Maidenhead, UK).
Apoptosis detection
Apoptotic cells were detected 24 or 48hours after UCA treatment
using the TACS Annexin V-FITC (R&D Systems) according to the
manufacturer’s instructions. Samples were analyzed by flow
cytometry as early apoptotic cells (annexin V-FITC positive), late
apoptotic cells (annexin V and propidium iodide positive), dead cells
(propidium iodide positive), and viable cells (unstained). For
measurement of mono- and oligonucleosome release into the
cytoplasm, cell death detection ELISAplus (Roche Diagnostics
GmbH, Penzberg, Germany) was used, according to the manufac-
turer’s instructions. The enrichment factor was calculated using the
following formula: absorbance of treated sample/absorbance of PBS
control.
Immunoblotting
Following UCA treatment, cells were washed with PBS, harvested
using a scraper and solubilized in cold lysis buffer. Then, 10mg
of cell lysate protein was separated on a NuPAGE 4–12% Bis-Tris gel
(Invitrogen) and subsequently electrotransferred to a polyvinylidene
difluoride membrane (Invitrogen) following the manufacturer’s
instructions. After blocking, the membrane was probed with primary
antibody and then secondary antibody. The protein bands on the
blots were detected with enhanced chemiluminescence reagents
mix (GE Healthcare UK, Little Chalfont, UK) according to the
manufacturer’s instructions. The densitometric analysis of each band
was performed using Image J software (National Institutes of Health,
Bethesda, MD).
Statistical analyses
For all analyses, Student’s unpaired t-test was performed using SPSS
11.5 software (SPSS, Chicago, IL). Values of Po0.05 were
considered significant.
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